GE awakens to success in PACSThe PACS market appears to have witnessed the awakening of sleeping giant.The giant is GE Medical Systems, which finally seems to be realizing the promise of PACS after years of Rip Van Winkle-like hibernation.
The PACS market appears to have witnessed the awakening of sleeping giant.
The giant is GE Medical Systems, which finally seems to be realizing the promise of PACS after years of Rip Van Winkle-like hibernation. Although Agfa and Siemens currently control the lion's share of the market (with numerous others battling for a piece of the action), GE can no longer be underestimated.
GE has kept a low profile in PACS throughout the year, but indications are that the Milwaukee company is enjoying unprecedented success in digital image management. Insiders report that the vendor is on track to record $80 million in orders this year for PACS equipment, with several luminary sites among its large-scale installations.
The achievement comes after years of GE missteps in the modality. GE has offered multiple forms of PACS products in the market since the early 1980s, such as its partnership with IBM on the Integrated Diagnostics PACS, but with little success. GE's purchase of Lockheed Martin's PACS unit in 1997 signaled the beginning of the turnaround, and that movement has gained steam now that GE has hired many of the PACS market's leading lights to spearhead its Integrated Imaging Solutions division.
What impact will GE's success have on other companies in the industry? Fortunately, the PACS market is growing at such a pace that everyone can be satisfied. But the rise of GE may be a sign that the big multimodality vendors are finally claiming PACS turf from many of the smaller companies that pioneered the industry.
Michael J. Cannavo, president,
Image Management Consultants
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.